Prasugrel/aspirin - Torrent Pharmaceuticals

Drug Profile

Prasugrel/aspirin - Torrent Pharmaceuticals

Alternative Names: Aspirin/Prasugrel; Prax A 75

Latest Information Update: 06 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Torrent Pharmaceuticals
  • Class Cyclopropanes; Fluorobenzenes; Nonsteroidal anti-inflammatories; Salicylic acids; Small molecules; Thienopyridines
  • Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide stimulants; Platelet ADP receptor antagonists; Platelet aggregation inhibitors; Purinoceptor P2Y12 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Acute coronary syndromes

Most Recent Events

  • 12 Sep 2016 Torrent Pharmaceuticals plans a phase IV trial for Acute coronary syndrome in India (CTRI/2016/08/007228)
  • 31 Aug 2016 Launched for Acute coronary syndromes in India before August 2016 (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top